Jenne Kyle 4
4 · IONIS PHARMACEUTICALS INC · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-01-02+18,700→ 18,700 totalExercise: $34.69From: 2026-01-02Exp: 2035-01-01→ Common Stock (18,700 underlying)
Footnotes (1)
- [F1]Grant on 01/02/2025 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2020 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2025. 25% of the shares subject to the option will vest and become exercisable on 01/02/2026. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.